Compare TMDX & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMDX | DGII |
|---|---|---|
| Founded | 1998 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 2019 | 1995 |
| Metric | TMDX | DGII |
|---|---|---|
| Price | $83.33 | $80.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $148.22 | $48.80 |
| AVG Volume (30 Days) | ★ 937.7K | 351.8K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 382.18 | 77.05 |
| EPS | 0.61 | ★ 1.00 |
| Revenue | ★ $605,494,000.00 | $430,221,000.00 |
| Revenue This Year | $24.25 | $18.71 |
| Revenue Next Year | $18.75 | $7.22 |
| P/E Ratio | $131.49 | ★ $83.01 |
| Revenue Growth | ★ 37.13 | 1.46 |
| 52 Week Low | $60.11 | $31.88 |
| 52 Week High | $156.00 | $83.42 |
| Indicator | TMDX | DGII |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 76.65 |
| Support Level | $66.18 | $61.86 |
| Resistance Level | $140.79 | N/A |
| Average True Range (ATR) | 4.14 | 3.12 |
| MACD | 0.63 | 1.40 |
| Stochastic Oscillator | 79.36 | 97.97 |
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.